发明名称 |
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE |
摘要 |
A compound of formula A is proposedwhich can be named methyl 4-[(2-flouro-3{[(6-methyl(3-pyridile)amino]carbonylamino}-phenyl)methyl]piperazinecarboxylate or a pharmaceutically acceptable salt thereof comprising a pharmaceutically acceptable excipient, vehicle or adjuvant and a compound of formula A or a pharmaceutically acceptable salt. A method is also proposed for treating cardiac failure in mammals comprising administration a mammal a therapeutically acceptable amount of the compound of formula A or a pharmaceutically acceptable salt or a pharmaceutical composition comprising the compound of formula A or a pharmaceutically acceptable salt. Wherein the heart failure is a congestive heart failure, including a systolic heart failure. |
申请公布号 |
EA016138(B1) |
申请公布日期 |
2012.02.28 |
申请号 |
EA20070000058 |
申请日期 |
2005.06.16 |
申请人 |
CYTOKINETICS, INC. |
发明人 |
MORGAN BRADLEY, P.;MUCI ALEX;LU PU-PING;KRAYNACK ERICA;TOCHIMOTO TODD;MORGANS DAVID |
分类号 |
A61K31/40;A61K31/42;A61K31/44;A61P9/04;C07D401/02;C07D401/04;C07D401/12 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|